Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | Chief Business Officer | Common Stock | 67.6K | $3.11M | $45.96 | Sep 27, 2024 | Direct |
Janux Therapeutics, Inc. | Chief Business Officer | Stock Option (right to buy) | 101K | Sep 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Sep 27, 2024 | 3 | -$2.09M | 4 | Sep 27, 2024 | Chief Business Officer |
JANX | Janux Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Chief Business Officer |
JANX | Janux Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Business Officer |
JANX | Janux Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Business Officer |
JANX | Janux Therapeutics, Inc. | Jun 10, 2021 | 0 | $0 | 3 | Jun 10, 2021 | Chief Business Officer |